These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
77 related items for PubMed ID: 3927035
1. [Study on the levels of anti-A, anti-B isoagglutinin titer in various kinds of concentrates for hemophilia treatment--with special regard to the manufacturing process of factor VIII concentrate]. Tomita Y, Inagaki M, Taki M, Miura T, Saito N, Sato R, Meguro T, Yamada K. Rinsho Ketsueki; 1985 Feb; 26(2):166-70. PubMed ID: 3927035 [No Abstract] [Full Text] [Related]
2. Hemolysis caused by factor VIII concentrates. Orringer EP, Koury MJ, Blatt PM, Roberts HR. Arch Intern Med; 1976 Sep; 136(9):1018-20. PubMed ID: 962445 [Abstract] [Full Text] [Related]
3. High frequency of low plasma haptoglobin values found in hemophilia A patients on prophylactic treatment with factor VIII concentrates - a sign of hemolysis? Egberg N, Blombäck M. Thromb Haemost; 1981 Aug 28; 46(2):554-7. PubMed ID: 6795743 [Abstract] [Full Text] [Related]
4. Levels of hepatitis B antigen and isoagglutinins in clinical concentrates of factor VIII and prothrombin complex. Wickerhauser M. Dev Biol Stand; 1974 Aug 28; 27():172-7. PubMed ID: 4463121 [No Abstract] [Full Text] [Related]
5. Hemophiliac with hemolytic anemia resulting from factor VIII concentrate. Soni NS, Patel AR, Vohra RM, Shah PC. Acta Haematol; 1977 Aug 28; 58(5):294-7. PubMed ID: 413305 [Abstract] [Full Text] [Related]
11. Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin. Santagostino E, Gringeri A, Tagliavacca L, Mannucci PM. Thromb Haemost; 1995 Aug 07; 74(2):619-21. PubMed ID: 8584995 [Abstract] [Full Text] [Related]
14. [Treatment of haemophilia with factor VIII inhibitor by giving isoagglutinin-free factor VIII concentrate (author's transl)]. Bartholomé K, Geiger H, Schimpf K. Dtsch Med Wochenschr; 1976 Aug 20; 101(34):1252-4. PubMed ID: 947734 [Abstract] [Full Text] [Related]
15. Purity of concentrates for substitution therapy: acceptable and undesirable contaminants--Madrid 1978. Scand J Haematol Suppl; 1980 Aug 20; 35():65-89. PubMed ID: 6770460 [No Abstract] [Full Text] [Related]
16. Hemophilia. Strategies for the treatment of inhibitor patients. Ingerslev J. Haematologica; 2000 Oct 20; 85(10 Suppl):15-20. PubMed ID: 11187863 [Abstract] [Full Text] [Related]